A Phase 3, Multicenter, Multi-country, Open-label, Randomized, Active-controlled Clinical Trial to Evaluate the Efficacy and Safety of Desidustat Versus Darbepoetin for the
Treatment of Anemia in Patients with Chronic Kidney Disease (CKD) who are not on Dialysis.